Jessica Hopfield
Director · Editas Medicine, Inc.
- 2025
- Jun 22, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jessica Hopfield files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ashley McEvoy - $1.19M in PODD purchases and sales in the last 12 months
- Wayne A.I. Frederick - $543K in PODD purchases and sales in the last 12 months
- Michael R. Minogue - $500K in PODD purchases and sales in the last 12 months
- Elizabeth H. Weatherman - $497K in PODD purchases and sales in the last 12 months
- Timothy C. Stonesifer - $400K in PODD purchases and sales in the last 12 months
- Gilmore Neil O'Neill - $80K in EDIT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jessica Hopfield?
Jessica Hopfield is a corporate insider, tracked as Director of Editas Medicine, Inc. (EDIT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jessica Hopfield last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 4 filings going back to 2025.
Has Jessica Hopfield been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1.66M) across all tracked filings.
